Tim Schlidt of Palo Santo Discusses Why Psychedelics Therapy is the Future of End-of-Life Care Sep 13, 2021
Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104 Sep 9, 2021
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying… Sep 2, 2021
Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To… Aug 31, 2021
Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action in its Long-Acting Next… Aug 26, 2021
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders Aug 24, 2021
